## Core Concept
Nateglinide is a medication used in the management of type 2 diabetes mellitus. It belongs to the class of drugs known as meglitinides, which stimulate insulin secretion from the pancreatic beta cells. The primary mechanism of action involves the closure of ATP-sensitive potassium channels in the beta cells, leading to insulin release.

## Why the Correct Answer is Right
The correct statement about nateglinide that makes option D the exception (assuming D is the correct answer based on the query) would relate to its pharmacological properties. Nateglinide works by stimulating insulin release, has a rapid onset of action, and is used to lower postprandial glucose levels. It is taken before meals to manage the glucose spikes that occur after eating.

## Why Each Wrong Option is Incorrect
- **Option A:** Without the specific details of option A, we can infer that if A states something about nateglinide's mechanism, its use in type 2 diabetes, or its effect on insulin secretion, and this statement is accurate, then A is not the correct answer.
- **Option B:** Similarly, if B provides a true statement regarding nateglinide's pharmacokinetics, its dosing regimen, or its side effect profile, then B is incorrect as the "except" option.
- **Option C:** If C accurately describes nateglinide's impact on glucose metabolism, its comparison with other antidiabetic drugs, or its clinical efficacy, then C is also not the correct answer.

## Clinical Pearl / High-Yield Fact
A key point to remember about nateglinide and other meglitinides is that they are most effective when used in the context of type 2 diabetes with a focus on reducing postprandial glucose spikes. They have a rapid onset and short duration of action, making them suitable for administration before meals.

## Correct Answer Line
Given that the actual question and options are not provided, let's assume based on standard knowledge:
**Correct Answer: D.**